Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m 2 or higher (obesity) 27 kg/m 2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
The vendor has a relatively thin review footprint on major research forums compared to more established competitors
Use once daily, preferably in the evening
risks, including the consequences of further loss of lean mass, especially in frail, sarcopenic patients
For compounds with complex signaling profiles, that level of control becomes even more important
Protein helps preserve muscle mass during weight loss and helps you feel fuller between meals, which is especially important when starting Wegovy, when your appetite signals might be changing